The New England Journal of Medicine (NEJM) published the first study demonstrating that Rotarix™, GlaxoSmithKline's rotavirus vaccine, significantly prevented severe rotavirus gastroenteritis during the first year of life in African babies. In the study Rotarix prevented the disease in 61.2% of these infants. The study also showed that Rotarix...
http://digg.com/u1LkhC
No comments:
Post a Comment